Fidelity Investments
CASI

Fidelity Investments’s CASI Pharmaceuticals CASI Stock Holding History

Fidelity Investments’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-500
Closed -$1.8K – 5395
2024
Q1 		$1.8K Buy
+500
New +$2.69K ﹤0.01% 4713
2021
Q2 		– Sell
-55
Closed -$1K – 4286
2021
Q1 		$1K Buy
55
+54
+5,400% +$1.52K ﹤0.01% 3806
2020
Q4 		$0 Buy
+1
New +$22 ﹤0.01% 3850
2019
Q4 		– Sell
-90
Closed -$3K – 3804
2019
Q3 		$3K Buy
90
+86
+2,150% +$2.76K ﹤0.01% 3476
2019
Q2 		$0 Buy
+4
New +$128 ﹤0.01% 3758
2018
Q4 		– Sell
-8
Closed – – 3554
2018
Q3 		$0 Buy
+8
New +$558 ﹤0.01% 3528

Other funds holding CASI

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return